News Warner Logo

News Warner

‘Shampoo’ could protect against hair loss during chemo

‘Shampoo’ could protect against hair loss during chemo

  • Researchers at Michigan State University have developed a shampoo-like gel that could protect hair from falling out during chemotherapy treatment.
  • The gel, containing lidocaine and adrenalone, restricts blood flow to the scalp, preventing most of the chemotherapy drugs from reaching the hair follicles and causing hair loss.
  • The gel is designed to be temperature responsive, becoming thicker at body temperatures and thinner when exposed to cooler temperatures, making it easy to wash away.
  • Current solutions for chemotherapy-induced alopecia are limited, with cold caps being expensive and having extensive side effects, making this new gel a promising alternative.
  • The researchers hope to obtain funding to move the gel into clinical trials and eventually human patients, aiming to improve the quality of life for cancer patients experiencing hair loss during treatment.

A woman undergoes a chemotherapy treatment while wearing a bandana on her head.

Researchers have developed a shampoo-like gel that has been studied in animal models and could protect hair from falling out during chemotherapy treatment.

Baldness from chemotherapy-induced alopecia causes personal, social, and professional anxiety for everyone who experiences it.

Currently, there are few solutions—the only ones that are approved are cold caps worn on the patient’s head, which are expensive and have their own extensive side effects.

Bryan Smith, an associate professor in the Michigan State University College of Engineering and with MSU’s Institute for Qualitative Health Science and Engineering, has developed a gel the consistency of shampoo that he hopes will help protect patients’ hair throughout treatment.

When Smith was a trainee at Stanford University, he learned and used a process that inverted the typical engineering process, seeking to objectively identify and completely characterize critical clinical needs prior to solving them.

“This unmet need of chemotherapy-induced alopecia appealed to me because it is adjacent to the typical needs in medicine such as better treatments and earlier, more accurate diagnostics for cancer,” Smith says.

“This is a need on the personal side of cancer care that, as an engineer, I didn’t fully recognize until I began interviewing cancer physicians and former cancer patients about it. Once I understood, it became clear to me that better solutions are very important to many cancer patients’ quality of life.”

This rigorous process of specifying the need, identifying possible solutions, developing an initial prototype, and refining and testing it led to the development of a gel described in a new paper in Biomaterials Advances.

The gel is a hydrogel, which absorbs a lot of water and provides long-lasting delivery of drugs to the patient’s scalp. The hydrogel is designed to be applied to the patient’s scalp before the start of chemotherapy and left on their head as long as the chemotherapy drugs are in their system—or until they are ready to easily wash it off.

During chemotherapy treatment, chemotherapeutic drugs circulate throughout the body. When these drugs reach the blood vessels surrounding the hair follicles on the scalp, they kill or damage the follicles, which releases the hair from the shaft and causes it to fall out. The gel, containing the drugs lidocaine and adrenalone, prevents most of the chemotherapy drugs from reaching the hair follicle by restricting the blood flow to the scalp. Dramatic reduction in drugs reaching the follicle will help protect the hair and prevent it from falling out.

To support practical use of this “shampoo,” the gel is designed to be temperature responsive. For example, at body temperatures the gel is thicker and clings to the patient’s hair and scalp surface. When the gel is exposed to slightly cooler temperatures, the gel becomes thinner and more like a liquid that can be easily washed away.

Smith and his team hope to obtain federal and/or venture funding to move this research forward into clinical trials and, eventually, to human patients.

“The research has the potential to help many people,” Smith says. “All the individual components are well-established, safe materials, but we can’t move forward with follow-up studies and clinical trials on humans without the support of substantial funding.”

Source: Michigan State University

The post ‘Shampoo’ could protect against hair loss during chemo appeared first on Futurity.

link

Q. What is the problem that Bryan Smith and his team are trying to solve?
A. The problem they are trying to solve is hair loss during chemotherapy treatment, also known as chemotherapy-induced alopecia.

Q. Why is this a significant issue for cancer patients?
A. Hair loss from chemotherapy-induced alopecia causes personal, social, and professional anxiety for everyone who experiences it.

Q. What is the current solution for preventing hair loss during chemotherapy?
A. The only approved solutions are cold caps worn on the patient’s head, which are expensive and have extensive side effects.

Q. How did Bryan Smith develop his gel-like solution to prevent hair loss?
A. He used a process that inverted the typical engineering process, seeking to objectively identify and completely characterize critical clinical needs prior to solving them.

Q. What is the consistency of the gel developed by Bryan Smith?
A. The gel has the consistency of shampoo.

Q. How does the gel work to prevent hair loss during chemotherapy?
A. It restricts blood flow to the scalp, preventing most of the chemotherapy drugs from reaching the hair follicle and killing or damaging it.

Q. What is special about the temperature responsiveness of the gel?
A. The gel becomes thinner and more like a liquid when exposed to slightly cooler temperatures, making it easy to wash away.

Q. Who developed the gel-like solution?
A. Bryan Smith, an associate professor in the Michigan State University College of Engineering.

Q. Why does funding from federal or venture sources matter for this research?
A. Funding is necessary to move the research forward into clinical trials and eventually human patients, as all individual components are well-established and safe materials.

Q. What is the potential impact of this research on people?
A. The research has the potential to help many people by providing a solution to prevent hair loss during chemotherapy treatment.